Eagle Pharmaceuticals to Present at September Healthcare Conferences
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Sep 1, 2021--
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at two upcoming investor conferences as follows:
Morgan Stanley 19th Annual Global Healthcare Conference
Tuesday, September 14, 2021
2:00 p.m. ET
2021 Cantor Virtual Global Healthcare Conference
Tuesday, September 28, 2021
4:40 p.m. ET
The presentations will be webcast live at the aforementioned times, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors section.
About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX ®, BENDEKA ®, BELRAPZO ®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210901006020/en/
CONTACT: Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS
SOURCE: Eagle Pharmaceuticals, Inc.
Copyright Business Wire 2021.
PUB: 09/01/2021 05:00 PM/DISC: 09/01/2021 05:02 PM